Home > PE Ratio > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of ALEMBIC PHARMACEUTICALS is 32.36.

Share Price ₹1,062.7Jan 06,2025
Market Cap ₹20,891.7 Cr
Earnings-TTM₹645.6 CrTTM-Consolidated Results
Price/Earnings32.36xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ALEMBIC PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ALEMBIC PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹20,891.7 Cr] as on Jan 06,2025

(/) Earnings [ ₹645.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 32.36x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ALEMBIC PHARMACEUTICALS , the investors are currently willing to pay 32.36 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALEMBIC PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ALEMBIC PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of ALEMBIC PHARMACEUTICALS


PE Ratio Performance Analysis for ALEMBIC PHARMACEUTICALS

- ALEMBIC PHARMACEUTICALS 's latest p/e ratio is 32.36x.

- ALEMBIC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 23.30x.

- ALEMBIC PHARMACEUTICALS 's operated at median p/e ratio of 27.97x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ALEMBIC PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 31.35x.

- ALEMBIC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 12.14x.


How does ALEMBIC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ALEMBIC PHARMACEUTICALS 645.6032.3620,891.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.79443,145.0
CIPLA LTD4,485.2226.84120,379.0
DR REDDYS LABORATORIES LTD5,406.8020.84112,701.0
ZYDUS LIFESCIENCES LTD4,298.9022.5196,774.5
DIVIS LABORATORIES LTD1,836.0085.12156,280.0
MANKIND PHARMA LTD2,124.8656.02119,028.0
TORRENT PHARMACEUTICALS LTD1,802.0063.00113,526.0
LUPIN LTD2,651.9440.56107,569.0
AUROBINDO PHARMA LTD3,598.8321.2076,299.9
ABBOTT INDIA LTD1,284.6649.5263,619.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALEMBIC PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.84x
Max industry PE 85.12x
Median industry PE 39.79x
Average industry PE 41.62x



You may also like the below Video Courses